Carl Dambkowski, Director: Oruka Therapeutics ORKA Planned sale · Filed 05/21

Trade details

Type: Planned sale notice
Stock: Oruka Therapeutics ORKA
Person: Carl DambkowskiDirector
Planned sale date: 26/05/21
Filed: 26/05/21

0.2% of shares outstanding to be sold

Oruka Therapeutics trades, last 26 weeks

What else happened in Oruka Therapeutics around then

Filed or reported within 30 days of the trade day · 04/21~06/20

Carl Dambkowski's recent trades

Carl DambkowskiChief Medical Officer
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$3.5M
26,400 sh
$3.5M
Filed 06/24
Traded 06/22
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$1.6M
22,417 sh
$1.6M
Filed 06/12
Traded 06/11
Carl DambkowskiDirector
Sell10b5-1 planOruka Therapeutics
Sell10b5-1 plan
Oruka Therapeutics
ORKA
$882.2K
12,583 sh
$882.2K
Filed 06/12
Traded 06/12
Carl DambkowskiDirector
Planned sale10b5-1 planOruka Therapeutics
Planned sale10b5-1 plan
Oruka Therapeutics
ORKA
$2.2M
35,000 sh
$2.2M
Filed 06/11
Traded 06/11
Carl DambkowskiChief Medical Officer
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$432.9K
5,500 sh
$432.9K
Filed 06/05
Traded 06/03

Carl Dambkowski, Director — plans to sell 105,000 sh of Oruka Therapeutics ORKA · $6.4M · around 05/21 · 10b5-1 plan | Whalegun